Inhaled Treprostinil for PAH: Open-label Extension
NCT01557660
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
inhaled treprostinil
Sponsor
United Therapeutics